COMMUNIQUÉS West-GlobeNewswire

Immunomedics Announces Promotion Agreement With Janssen for Erdafitinib in the U.S.
08/04/2019
MORRIS PLAINS, N.J., April 08, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
3D Signatures Announces Name Change to Telo Genomics Corp.
08/04/2019
TORONTO, April 08, 2019 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V: DXD) (the “Company” or “3DS”) is pleased to announce that it has changed its corporate name to Telo Genomics Corp . effective April 08, 2019. [...]
Generex Biotechnology Corporation Appoints Mark J. Prioletti to the Board of Directors
08/04/2019
Sales & Marketing Executive Brings Global Expertise in Global Channel Marketing MIRAMAR, FL, April 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation ( www.generex.com ) (OTCQB: GNBT [...]
INmune Bio Announces Poster Presentation with New Data Regarding Neurodegenerative Disease Drug Candidate, XPro1595, at The European Conference on Neuroinflammation
08/04/2019
LA JOLLA, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today [...]
Montefiore St. Luke’s Cornwall Deploys Artifact Health’s Mobile Physician Query Solution to Reduce Administrative Burden on Physicians
08/04/2019
Hospital deploys Artifact solution in just four weeks BOULDER, Colo. and NEWBURGH, N.Y., April 08, 2019 (GLOBE NEWSWIRE) -- Artifact Health , which provides the first and only mobile platform that streamlines the [...]
PRA Health Sciences Receives CRO Leadership Awards
08/04/2019
RALEIGH, N.C., April 08, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. is pleased to announce it has won a 2019 CRO Leadership Award in the following categories: Capabilities (Overall, Big Pharma, Small Pharma) [...]
Receptor Holdings Adds Alex Casdin to Board of Directors
08/04/2019
SEATTLE, April 08, 2019 (GLOBE NEWSWIRE) -- Alexander W. Casdin, Founder, CEO, and Portfolio Manager of Reneo Capital Management LP, has been named to the Board of Directors of Receptor Holdings (RHI). Mr. Casdin has a [...]
Medovex Corporation Closes Financing for a Total $7.2M Under Existing Securities Purchase Agreement
08/04/2019
ALPHARETTA, Ga., April 08, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced that on April 1, 2019, the Company entered into a securities purchase agreement with [...]
Share buy-back week 14/2019
08/04/2019
Announcement 8 April 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling up [...]
Sarepta Therapeutics’ Gene Therapy Limb-Girdle Muscular Dystrophy Type 2E Clinical Data has been Accepted for a Late-breaking Oral Presentation at the 2019 MDA Clinical and Scientific Conference
08/04/2019
--Six additional poster presentations highlighting data from Sarepta’s RNA and gene therapy programs also accepted-- CAMBRIDGE, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the [...]
Bellerophon Announces Agreement with FDA on Regulatory Approval Pathway for INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
08/04/2019
FDA Agrees to Primary Endpoint of Change in Moderate to Vigorous Physical Activity from Baseline to Week 16, Measured by Actigraphy FDA Also Agrees on Modification of Ongoing Phase 2b Study into a Phase 2/3 Trial, with [...]
Spero Therapeutics Highlights SPR994 Data at the 29th European Congress of Clinical Microbiology and Infectious Diseases
08/04/2019
Five presentations on SPR994 and cUTI resistance trends at ECCMID provide support for Phase 3 program and unmet need CAMBRIDGE, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi- [...]
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS)
08/04/2019
– New Allowance by U.S. Patent and Trademark Office Includes irritable bowel syndrome (IBS) test kit panel – IRVINE, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced today that the [...]
Auransa to Participate in BioCentury's 26th Annual Future Leaders in the Biotech Industry Conference
08/04/2019
PALO ALTO, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical need, today announced [...]
Managers’ transactions
08/04/2019
Company announcement No. 7/2019 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 About Chr. Hansen [...]
REPEAT - RavenQuest Secures Health Canada Cultivation License at Edmonton Facility
08/04/2019
VANCOUVER, British Columbia, April 08, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “ Company ” or “ RavenQuest ”) a federally-licensed producer of cannabis, is pleased to [...]
IntelGenx to Promote VetaFilm™ Oral Film Technology at Human Biotech & Animal Health Business Partnering Summit
08/04/2019
SAINT LAURENT, Quebec, April 08, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it will promote its proprietary VetaFilm™ oral [...]
Daré Bioscience Announces Publication of Pharmacokinetics Study of DARE-HRT1, a Potential Hormone Replacement Therapy, in the Journal of Pharmaceutical Sciences
08/04/2019
SAN DIEGO, April 08, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced the article entitled “Pharmacokinetics and tolerability of a novel 17β-estradiol [...]
Opiant Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Data Supporting Potential of OPNT003, Nasal Nalmefene, for Treatment of Synthetic Opioid Overdose
08/04/2019
Data published online in the Journal of Pharmacology and Experimental Therapeutics SANTA MONICA, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT), a specialty pharmaceutical company [...]

Pages